Impaired insulin turnover in islets from type 2 diabetic patients

Islets

Volumn 2, Issue 1, 2010, Pages 30-36

  Ehehalt, Florian ^a,b   Knoch, Klaus Peter ^a,b   Erdmann, Katja ^a,b   Krautz, Christian ^a,b   Jäger, Melanie ^a,b   Steffen, Anja ^a,b   Wegbrod, Carolin ^a,b   Meisterfeld, Ronny ^a,b   Kersting, Stephan ^a,b   Bergert, Hendrik ^a,b   Kuhlisch, Eberhard ^a   Bornstein, Stefan Robert ^a,b   Bonifacio, Enzio ^a,b   Saeger, Hans Detlev ^a,b   Solimena, Michele ^a,b  

^a CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Glucose stimulated insulin secretion; Insulin biosynthesis degradation; Isolated human islets; Polypyrimidine tract binding protein 1; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; POLYPYRIMIDINE TRACT BINDING PROTEIN; POLYPYRIMIDINE TRACT BINDING PROTEIN 1; UNCLASSIFIED DRUG; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; PTBP1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC PATIENT; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SYNTHESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS SURGERY; PROTEIN TRANSPORT; ACTIVE TRANSPORT; BIOSYNTHESIS; CASE CONTROL STUDY; CELL NUCLEUS; CELL SEPARATION; DRUG EFFECT; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; TISSUE DISTRIBUTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADULT; AGED; CASE-CONTROL STUDIES; CELL NUCLEUS; CELL SEPARATION; DIABETES MELLITUS, TYPE 2; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; POLYPYRIMIDINE TRACT-BINDING PROTEIN; PROTEIN PROCESSING, POST-TRANSLATIONAL; TISSUE DISTRIBUTION;

EID: 77953434958     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.2.1.10098     Document Type: Article

References (30)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414:782-7.
2. Diamond J. The double puzzle of diabetes. Nature 2003; 423:599-602.
3. Polonsky KS, Sturis J, Bell GI. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulindependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996; 334:777-83.
4. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003; 46:3-19.
5. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444:840-6.
6. Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009; 52:1003-12.
7. Guest PC, Rhodes CJ, Hutton JC. Regulation of the biosynthesis of insulin-secretory-granule proteins. Co-ordinate translational control is exerted on some, but not all, granule matrix constituents. Biochem J 1989; 257:431-7.
8. Seissler J, Nguyen TB, Aust G, Steinbrenner H, Scherbaum WA. Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells. Diabetes 2000; 49:1137-41.
9. 2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion. EMBO J 2001; 20:4013-23.
10. Alarcon C, Lincoln B, Rhodes CJ. The biosynthesis of the subtilisin-related proprotein convertase PC3, but no that of the PC2 convertase, is regulated by glucose in parallel to proinsulin biosynthesis in rat pancreatic islets. J Biol Chem 1993; 268:4276-80.
11. Martin SK, Carroll R, Benig M, Steiner DF. Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans. FEBS Lett 1994; 356:279-82.
12. Halban PA, Wollheim CB. Intracellular degradation of insulin stores by rat pancreatic islets in vitro. An alternative pathway for homeostasis of pancreatic insulin content. J Biol Chem 1980; 255:6003-6.
13. Sandberg M, Borg LA. Intracellular degradation of insulin and crinophagy are maintained by nitric oxide and cyclo-oxygenase 2 activity in isolated pancreatic islets. Biol Cell 2006; 98:307-15.
14. Knoch KP, Bergert H, Borgonovo B, Saeger HD, Altkruger A, Verkade P, et al. Polypyrimidine tractbinding protein promotes insulin secretory granule biogenesis. Nat Cell Biol 2004; 6:207-14.
15. Tillmar L, Welsh N. Hypoxia may increase rat insulin mRNA levels by promoting binding of the polypyrimidine tract-binding protein (PTB) to the pyrimidinerich insulin mRNA 3'-untranslated region. Mol Med 2002; 8:263-72.
16. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102-10.
17. Fernandez-Alvarez J, Conget I, Rasschaert J, Sener A, Gomis R, Malaisse WJ. Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1994; 37:177-81.
18. Lin JM, Fabregat ME, Gomis R, Bergsten P. Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. Diabetes 2002; 51:988-93.
19. Deng S, Vatamaniuk M, Huang X, Doliba N, Lian MM, Frank A, et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004; 53:624-32.
20. Marchetti P, Del Guerra S, Marselli L, Lupi R, Masini M, Pollera M, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004; 89:5535-41.
21. Del Guerra S, Lupi R, Marselli L, Masini M, Bugliani M, Sbrana S, et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 2005; 54:727-35.
22. Anello M, Lupi R, Spampinato D, Piro S, Masini M, Boggi U, et al. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 2005; 48:282-9.
23. Marchetti P, Del Prato S, Lupi R, Del Guerra S. The pancreatic beta-cell in human Type 2 diabetes. Nutr Metab Cardiovasc Dis 2006; 16:3-6.
24. Howell SL, Taylor KW. The secretion of newly synthesized insulin in vitro. Biochem J 1967; 102:922-7.
25. Sando H, Grodsky GM. Dynamic synthesis and release of insulin and proinsulin from perifused islets. Diabetes 1973; 22:354-60.
26. Halban PA. Differential rates of release of newly synthesized and of stored insulin from pancreatic islets. Endocrinology 1982; 110:1183-8.
27. Gold G, Gishizky ML, Grodsky GM. Evidence that glucose "marks" beta cells resulting in preferential release of newly synthesized insulin. Science 1982; 218:56-8.
28. Duncan RR, Greaves J, Wiegand UK, Matskevich I, Bodammer G, Apps DK, et al. Functional and spatial segregation of secretory vesicle pools according to vesicle age. Nature 2003; 422:176-80.
29. Knoch KP, Meisterfeld R, Kersting S, Bergert H, Altkruger A, Wegbrod C, et al. cAMP-dependent phosphorylation of PTB1 promotes the expression of insulin secretory granule proteins in beta cells. Cell Metab 2006; 3:123-34.
30. Heni M, Haupt A, Schäfer SA, Guthoff M, Kirchhoff K, Ketterer C, et al. Polymorphism rs11085226 in the gene encoding Polypyrimdine-tract-binding protein 1 negatively affects glucose-stimulated insulin secretion. 2009; submitted.